Abstract
Eight bismuth(III) complexes derived from the simple α-hydroxycarboxylic acids; gluconic (H6-glu), tartaric (H4-tar), mandelic (H2-man), malic (H3-mal) and glycolic (H2-gly) have been synthesised and characterised. The complexes are formed through direct treatment of the organic acids with Bi(NO3)3·5H2O ([Bi(H2-tar)(H3-tar)] 2, [Bi(mal)(NO3)(H2O)2] 6, [Bi(gly)(NO3)(H2O)] 8) or Bi(OtBu)3 ([Bi(H-tar)(H2O)2] 1, [Bi(man)(H-man)(H2O)] 4, [Bi2(H-mal)3] 5, [Bi(gly)(H-gly)] 7), or through metathesis of the sodium salts with Bi(NO3)3·5H2O ([Bi(H3-glu)] 3). Reactions with both glucuronic and mucic acid proved to be unsuccessful. Small crystals of [Bi(gly)4(NO3)4(H2O)4]·5H2O 8 were obtained from aqueous solution and analysed by synchrotron X-ray diffraction. The data were relatively poor but composition and connectivity were established, confirming and supporting other analyses. Those complexes which displayed sufficient solubility; 2, 4, 7 and 8, were tested for their anti-Leishmanial activity against parasite promastigotes and amastigotes, and for toxicity against human fibroblast cells. All four complexes and their parent acids showed no toxicity towards either the promastigotes or fibroblast cells. However, the two glycolate complexes showed selective toxicity towards amastigotes with complex 8 providing for a low % viability of 1.8 ± 0.9 at 50.0 µM.
Graphical Abstract
Novel bismuth(III) complexes derived from α-hydroxycarboxylic acids have been synthesised, characterised and assessed for their anti-leishmanial activity. The glycolate complexes are selectively toxic against parasite amastigotes, with all complexes being non-toxic towards promastigotes and human fibroblast cells.
Similar content being viewed by others
References
Malik S, Kumar S, Choudhary A, Kumar A, Singh A, Garima A (2010) J Chem Pharm Res 2:70–91
Sheets D, Mubayi A, Kojouharov HV (2010) Int J Env Health Res 20:415–430
Ready PD (2013) Ann Rev Entomol 58:227–250
Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, Peters N, Adlem E, Tivey A, Aslett M, Kerhornou A, Ivens A, Fraser A, Rajandream MA, Carver T, Norbertczak H, Chillingworth T, Hance Z, Jagels K, Moule S, Ormond D, Rutter S, Squares R, Whitehead S, Rabbinowitsch E, Arrowsmith C, White B, Thurston S, Bringaud F, Baldauf SL, Faulconbridge A, Jeffares D, Depledge DP, Oyola SO, Hilley JD, Brito LO, Tosi LR, Barrell B, Cruz AK, Mottram JK, Smith DF, Berriman M (2007) Nat Gen 39:839–847
Ogden BO, Melby PC (2009) In: Moselio S (ed) Encyclopedia of microbiology, 3rd edn. Academic Press, Oxford, pp 663–673
Bates PA (2007) Int J Paristol 37:1097–1106
Singh S, Sivakumar RJ (2004) J Infect Chemother 10:307–315
Frézard F, Martins PS, Barbosa MCM, Pimenta AMC, Ferreira WA, de Melo JE, Mangrum JB, Demicheli C (2008) J Inorg Biochem 102:656–665
Hepburn NC, Nolan J, Fenn I, Herd RM, Neilson JMM, Sutherland GR, Fox KAA (1994) QJM 87:465–472
Oliveira LF, Schubach AO, Martins MM, Passos SL, Oliveira RV, Marzochi MC, Andrade CA (2011) Acta Trop 118:87–96
Hepburn NC, Siddique I, Howie AF, Beckett GJ, Hayes PC (1994) Trans R Soc Trop Med Hyg 88:453–455
Rodrigues MLO, Costa RS, Souza CS, Foss NT, Roselino AMF (1999) Rev Instit Med Trop São Paulo 41:33–37
del Rosal T, Artigao FB, Miguel MJG, de Lucas R, del Castillo F (2010) J Trop Ped 56:122–124
Gasser RA Jr, Magill AJ, Oster CN, Franke ED, Grogl M, Berman JD (1994) Clin Infect Dis 18:83–90
Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PC, Murray HW (2000) Clin Infect Dis 31:1104–1107
Richard JV, Werbovetz KA (2010) Curr Op Chem Biol 14:447–455
Shoeib T, Sharp BL (2012) Metallomics 4:1308–1320
Yang N, Sun H (2010) Biological chemistry of arsenic, antimony and bismuth. Wiley, New Jersey, pp 53–81. doi:10.1002/9780470975503
Ge R, Sun H (2007) Acc Chem Res 40:267–274
Berman JD, Gallalee JV, Best JM (1987) Biochem Pharmacol 36:197–201
Demicheli C, Frézard F, Lecouvey M, Garnier-Suillerot A (2002) Biochim Biophys Acta 1570:192–198
Lucumi A, Robledo S, Gama V, Saravia NG (1998) Antimicrob Agents Chemother 42:1990–1995
Brochu C, Wang J, Roy G, Messier N, Wang XY, Saravia NG, Ouellette M (2003) Antimicrob Agents Chemother 47:3073–3079
Andrews PC, Frank R, Junk PC, Kedzierski L, Kumar I, MacLellan JG (2011) J Inorg Biochem 105:454–461
Andrews PC, Junk PC, Kedzierski L, Peiris RM (2013) Aust J Chem 66:1297–1305
Andrews PC, Blair VL, Ferrero RL, Junk PC, Kedzierski L, Peiris RM (2014) Dalton Trans 43:1279
McPhillips TM, McPhillips SE, Chiu HJ, Cohen AE, Deacon AM, Allis PJ, Garman E, Gonzales A, Sauter NK, Phizackerley RP, Soltis SM, Kuhn P (2002) J Synchrotron Radiat 9:401–406
Kabsch WJ (1993) J Appl Crystallogr 26:795–800
CrysAlisPro v1.171.34.36, Oxford Diffraction Ltd (Agilent Technologies) Oxfordshire, 2010
Mikus J, Steverding D (2000) Parasitol Int 48:265–269
Kedzierski L, Curtis JM, Kaminska M, Jodynis-Liebert J, Murias M (2007) Parasitol Res 102:91–97
Kedzierski L, Montgomery J, Bullen D, Curtis J, Gardiner E, Jimenez-Ruiz A (2004) Handman. J Immunol 172:4902–4906
Herrmann WA, Herdtweck E, Scherer W, Kiprof P, Pajdla L (1993) Chem Ber 126:51–56
Herrmann WA, Herdtweck E, Pajdla L (1991) Inorg Chem 30:2579–2581
Asato E, Driessen WL, de Graaff RAG, Hulsbergen FB, Reedijk J (1991) Inorg Chem 30:4210–4218
Asato E, Katsura K, Mikuriya M, Fujii T, Reedijk J (1992) Chem Lett 10:1967–1970
Asato E, Katsura K, Mikuriya M, Fujii T, Reedijk J (1993) Inorg Chem 32:5322–5329
Asato E, Katsura K, Mikuriya M, Turpeinen U, Mutikainen I, Reedijk J (1995) Inorg Chem 34:2447–2454
Barrie PJ, Djuran MI, Mazid MA, McPartlin M, Sadler PJ, Scowen IJ, Sun H (1996) J Chem Soc Dalton Trans 12:2417–2422
Antsyshkina AS, Sadikov GG, Kuvshinova TB, Skorikov VM, Sergienko VS (2006) Russ J Inorg Chem 51:374–385
Yang N, An Y, Cai J-W, Hu L-H, Zeng Y-B, Mao Z-W, Chen G-H, Sun H (2010) Sci China Chem 53:2152–2158
Sagatys DS, O’Reilly EJ, Patel S, Bott RC, Lynch DE, Smith G, Kennard CHL (1992) Aust J Chem 45:1027–1034
Kiprof P, Scherer W, Pajdla L, Herdtweck E, Herrmann WA (1992) Chem Ber 125:43–46
Luqman A, Blair VL, Brammananth R, Crellin PK, Coppel RL, Kedzierski L, Andrews PC (2015) Eur J Inorg Chem 2015:725–733
Gourbal B, Sonuc N, Bhattacharjee H, Legare D, Sundar S, Ouellette M, Rosen BP, Mukhopadhyay R (2004) J Biol Chem 279:31010–31017
Brochu C, Wang J, Roy G, Messier N, Wang X-Y, Saravia NG, Ouellette M (2003) Antimicrob Agents Chemother 47:3073–3079
Novozhilova NM, Bovin NV (2010) Biochemistry 75:686–694
Secundino N, Kimblin N, Peters NC, Lawyer P, Capul AA, Beverley SM, Turco SJ, Sacks D (2010) Cell Microbiol 12:906–918
Piani A, Ilg T, Elefanty AG, Curtis J, Handman E (1999) Microb Infect 1:589–599
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Loh, A., Ong, Y.C., Blair, V.L. et al. Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major . J Biol Inorg Chem 20, 1193–1203 (2015). https://doi.org/10.1007/s00775-015-1299-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-015-1299-6